The impact of the MSH3 Ala1045Thr and MSH6 557G > T variants on various clinicopathological parameters, such as stage, tumor extension, lymph node invasion, and metastasis, was assessed (Supplementary Table 1). This evidence concerns the gene MSH6 and neoplasm.